Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Efficacy of the Patent Foramen Ovale Suture System for the Closure of Patent Foramen Ovale

NCT: NCT07726927 · NOT_YET_RECRUITING

NCT IDNCT07726927
StatusNOT_YET_RECRUITING
Start Date2026-06-30
Completion2032-07-31
SponsorShenzhen Bihe Medical Co., Ltd (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, multicenter, randomized controlled, non-inferiority clinical trial to evaluate the efficacy and safety of the patent foramen ovale suture system in the closure treatment of patent foramen ovale. A parallel controlled comparison will be conducted using the Amplatzer PFO Occluder manufactured by Abbott Medical Devices (Shanghai) co., Ltd. as the control device, to evaluate the safety and efficacy of the Patent Foramen Ovale Suture System in the closure treatment of patent foramen ovale.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑